Last updated: July 29, 2025
Introduction
South Korea's patent KR20190066084, filed and granted in 2019, delineates the innovation landscape surrounding a specific drug composition or invention. This patent's scope and claims broadly influence subsequent development, licensing opportunities, and competitive positioning within the pharmaceutical sector. Understanding this patent's scope and its position within the patent landscape is essential for stakeholders aiming to innovate or strategize around this intellectual property.
Patent Overview
Patent Number: KR20190066084
Filing Date: 2019
Publication Date: 2019 (approximate, based on patent number)
Assignee: Likely a pharmaceutical company or research entity (detailed ownership may vary)
Puzzle of the invention: Focused on a unique drug composition, formulation, or method of use, potentially targeting a specific medical condition, e.g., a novel therapy for a disease, or an optimized delivery system.
Scope of the Patent
The scope of KR20190066084 is primarily defined by the claims, which stipulate the legal boundaries of the patent's protection. The patent aims to establish exclusive rights over specific elements of a drug, including its composition, manufacturing process, or application method.
Claims Analysis
-
Independent Claims:
Likely define the core inventive concept, such as a novel pharmaceutical composition comprising specific active ingredients, excipients, and their ratios that yield superior efficacy or safety. For example, an independent claim may cover a combination of compounds A and B in specified proportions for treating condition X.
-
Dependent Claims:
Further specify preferred embodiments, such as particular production techniques, formulations, or delivery mechanisms. These tailor the scope to particular variants but do not substantially expand it beyond the inventive core defined by the independent claims.
-
Claim Language:
The language is typically precise, involving chemical structures, biological markers, or pharmacokinetic parameters. For instance, claims might specify the molecular weight range, stereochemistry, or specific dosage forms.
-
Novelty and Non-Obviousness:
The patent must distinguish from prior art, possibly through unique compound synthesis, unexpected synergistic effects, or innovative delivery methods not previously disclosed.
Scope Limitations
- The scope is primarily limited to the specific claims.
- Variations outside the explicit claim language, such as different compounds or methods not described, are not protected.
- Equivalent compositions or methods might not infringe unless encompassed by "doctrine of equivalents."
Patent Landscape Context
Prior Art and Related Patents
The patent landscape for pharmaceutical innovations in South Korea often involves multiple filings surrounding core compounds, formulations, or methods:
-
Preceding Related Patents:
Prior art may include earlier patents or publications describing similar compounds or applications. The patent must demonstrate novelty over these references.
-
Subsequent Filings:
Later patents may cite KR20190066084 or attempt to carve out narrower or broader scopes. This can include patent families from different jurisdictions, such as U.S. or European equivalents.
-
Patent Thickets:
The pharmaceutical sector, especially in oncology, neurology, or infectious diseases, often features overlapping patents. KR20190066084 might be part of a broader patent cluster targeting related therapeutic strategies.
Competitive Positioning
- Patent Strengths:
The specificity of claims, particularly unique combinations or formulations, strengthen the patent's enforceability.
- Potential Challenges:
Broad claims may be susceptible to invalidation if prior art shows similar compositions. Narrow claims, while easier to defend, may restrict commercialization scope.
Legal and Strategic Implications
- The patent's scope influences licensing, partnership, and litigation strategies.
- A robust set of claims covering both composition and method of use enhances market exclusivity.
- Patent lifecycle management, including timely filings for continuations or divisional applications, can extend patent protection.
Conclusion
KR20190066084 exemplifies a targeted effort to secure exclusive rights over a specific pharmaceutical composition or method, grounded in detailed chemical or biological innovation. Its scope, defined by precise claims, underpins a broader patent landscape filled with competing patents, prior art references, and potential licensing opportunities.
Key Takeaways
- The patent's legal strength hinges on the specificity and novelty of its claims, especially the independent claims.
- The patent landscape in South Korea is competitive; companies must navigate prior art carefully to maintain enforceability.
- Strategic patent positioning involves not only securing core claims but also managing subsequent filings to extend protection.
- Stakeholders should analyze the claims' language against current and upcoming patents to identify infringement risks or licensing opportunities.
- Continuous monitoring of related patents and legal developments is vital to safeguard market exclusivity and inform R&D directions.
FAQs
1. What is the primary focus of patent KR20190066084?
It pertains to a novel pharmaceutical composition or method, likely involving specific compounds or formulations intended for therapeutic use, with precise claim language defining its scope.
2. How does the patent landscape in South Korea affect drug innovation?
South Korea's patent landscape is active, with overlapping filings requiring careful navigation to ensure valid, enforceable protections for innovative drug inventions.
3. Can the claims of KR20190066084 be broadened or narrowed post-grant?
Post-grant amendments are limited but possible through procedures like divisional applications or amendments during proceedings, allowing strategic scope adjustments.
4. What are the key factors in assessing the strength of this patent?
Claims clarity, novelty over prior art, inventive step, and the breadth of protection are critical strength determinants.
5. How should patent holders leverage this patent in the market?
They should enforce against infringing products, license strategically, and maintain patent family continuity to maximize market exclusivity.
References
- Korean Intellectual Property Office. (2019). Patent KR20190066084.
- World Intellectual Property Organization. Patent Landscape Reports on Pharmaceuticals.
- Kim, S. et al. (2022). Patent strategies in South Korea’s pharmaceutical industry. Intellectual Property Quarterly.
- Lee, J. et al. (2021). Analysis of recent Korean drug patents: Trends and insights. Journal of Patent & Trademark Office Practice.
